Costs and Risks in the Management of Patients With Gastric Acid Hypersecretion

Abstract

Relapse is infrequent and generally mild with acid secreting status closely monitored. The ideal strategy to balance costs and testing awaits further study.

Presentation, response to lansoprazole therapy, and outcome of Zollinger–Ellison syndrome-like gastric acid hypersecretors

“…Close clinical follow-up is important, and routine gastric acid analysis was helpful in identifying a rise or fall in acid secretion which enhanced therapy. While our results support the use of endoscopy and gastric acid analysis for monitoring, the timing of such investigations is unknown [5]. Recurrent symptoms in the compliant patient should raise suspicion for a rise in acid secretion, the cause of which remains speculative.…”